Mundipharma hands Adi Prabowo marketing reins in Indonesia

Pharmaceutical company Mundipharma has appointed Adi Prabowo as its new head of marketing, digital and eCommerce. According to his LinkedIn profile, Prabowo (pictured) previously helmed the role of head of brand strategy and category development for almost two years. During that time, he was responsible for the marketing strategy of Betadine, new product development, creative, communication, digital and eCommerce business, his LinkedIn added. MARKETING-INTERACTIVE has reached out for additional information.

Prabowo first joined Mundipharma in 2016 as a marketing manager. He was subsequently promoted to senior marketing manager of Asia Pacific, Latin America, Africa and Middle East in 2018, and eventually head of brand strategy and category development. Prior to his time at Mundipharma, Prabowo was with Nutrifood Indonesia for approximately two and a half years. He took on the role of brand manager, digital and marketing communication, where he oversaw Nutrifood's heavenly blush yogurt portfolio. He was also previously in charge of Nutrifood's NutriSari brand from 2011 to 2013, before he moved over to Revlon in 2013 as product manager and marketing communication of its skin care, nail and fragrance categories.

Mundipharma is a global network of independent companies that manufacture pharmaceutical medicines and consumer healthcare products. It has a presence in over 120 countries across Asia Pacific, Africa, Canada, Europe, Latin America and the Middle East.

Last month, Mundipharma appointed Erik Nordkamp as its chief commercial officer for Asia Pacific, Latin America, and Middle East-Africa. In his role, Nordkamp reports to CEO Marc Princen, who was appointed in June 2020. In a press statement, Nordkamp said: "This is an exciting time for Mundipharma as we expand our global network and I feel proud to be taking responsibility for the key Asia Pacific, Latin America, and Middle East-Africa region. Think global, act local is how I envision we can deliver lasting change for patients." Additionally, Mundipharma also named Julie Dehaene-Puype as its chief commercial officer for its Europe markets.

Related article:
Study: China’s biopharmaceutical industry will enjoy rapid growth